http://www.xconomy.com/boston/2008/10/30/alnara-pharmaceuticals-aims-to-make-biotech-drugs-you-can-swallow-and-go-right-where-they-belong/ Business + Technology in the Exponential Economy Mon, 23 Nov 2009 06:44:11 -0600 http://wordpress.org/?v=2.8.6 hourly 1 http://www.xconomy.com/boston/2008/10/30/alnara-pharmaceuticals-aims-to-make-biotech-drugs-you-can-swallow-and-go-right-where-they-belong/comment-page-1/#comment-36696 Stewart Lyman Thu, 30 Oct 2008 23:24:10 +0000 http://www.xconomy.com/?p=5930#comment-36696 Interesting model. No lab space, no IP mentioned, no lead candidate, no disease to treat picked, no management group, and apparently behind the competition. Despite all this, they hope to be in the clinic in 18-24 months. One can only imagine how well vetted their first drug will be in this time frame. Sounds like a recipe for how not to build a company. This would be a good investment because.......? Interesting model. No lab space, no IP mentioned, no lead candidate, no disease to treat picked, no management group, and apparently behind the competition. Despite all this, they hope to be in the clinic in 18-24 months. One can only imagine how well vetted their first drug will be in this time frame. Sounds like a recipe for how not to build a company. This would be a good investment because…….?

]]>